Warburg Pincus seeks $10 bn plus for eye care company Bausch & Lomb
12 Dec 2012
Warburg Pincus has hired Goldman Sachs to explore a sale of eye care company Bausch & Lomb Inc, a deal thast may fetch the private equity firm more than $10 billion, Bloomberg today reported, citing two people familiar with the matter.
The New York-based private equity firm with $30 billion in assets under management, is seeking around $10 billion from the sale, but the asset may only fetch as much as $8 billion, said the report. Warburg Pincus had taken Bausch & Lomb private in 2007 for $3.7 billion.
The report said that Goldman Sachs has already approached health-care companies such as French drug giant Sanofi, UK-based GlaxoSmithKline and US-based Merck & Co, while it is yet to contact Abbott Laboratories.
Bausch & Lomb competes with Johnson & Johnson, Alcon, Allergan, MSD-Chibret and Ciba Vision, a unit of Novartis.
Warburg Pincus could also turn to an initial public offering as an alternative if a buyer cannot be found, the report added.
Founded in 1853 by two German immigrants, John Jacob Bausch, a trained optician and Henry Lomb, who put in the finance, Bausch & Lomb is one of the world's leading suppliers of eye health products, such as contact lenses and lens care products.
.jpg "RBI keeps repo rate unchanged as focus remains on inflation")
.jpg "Indian Oil, Panasonic team up for lithium-ion cell production in India")
